Genetics and personalized medicine--a role in statin therapy?

Jaideep Patel, Thura Abd, Roger S. Blumenthal, Khurram Nasir, H. Robert Superko

Research output: Contribution to journalArticle

Abstract

Pharmacogenetics uses the genetic variation in metabolic pathways to identify groups of patients who may respond differently in terms of therapeutic and adverse effects. Much clinical interest lies in drug metabolism and the opportunity to improve prescribing efficacy and safety. Owing to widespread use and increasing concern regarding side effects, statins are of significant interest in this area. Among other benefits, statins have been shown to improve lipid profiles and reduce coronary heart disease event rates in many populations. However, variability in drug response exists, and genetic variability may be a contributing factor. Our primary goal is to feature the most important genes involved in lipid metabolism, clinical outcomes, and statin-induced side effects, highlighting genome-wide association studies and the candidate gene approach.

Original languageEnglish (US)
Pages (from-to)384
Number of pages1
JournalCurrent Atherosclerosis Reports
Volume16
Issue number1
StatePublished - Jan 2014
Externally publishedYes

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Precision Medicine
Genome-Wide Association Study
Pharmacogenetics
Therapeutic Uses
Metabolic Networks and Pathways
Lipid Metabolism
Pharmaceutical Preparations
Genes
Coronary Disease
Therapeutics
Lipids
Safety
Population

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Genetics and personalized medicine--a role in statin therapy? / Patel, Jaideep; Abd, Thura; Blumenthal, Roger S.; Nasir, Khurram; Superko, H. Robert.

In: Current Atherosclerosis Reports, Vol. 16, No. 1, 01.2014, p. 384.

Research output: Contribution to journalArticle

Patel, J, Abd, T, Blumenthal, RS, Nasir, K & Superko, HR 2014, 'Genetics and personalized medicine--a role in statin therapy?', Current Atherosclerosis Reports, vol. 16, no. 1, pp. 384.
Patel, Jaideep ; Abd, Thura ; Blumenthal, Roger S. ; Nasir, Khurram ; Superko, H. Robert. / Genetics and personalized medicine--a role in statin therapy?. In: Current Atherosclerosis Reports. 2014 ; Vol. 16, No. 1. pp. 384.
@article{c9accdaae03c404da1a60c9a19b9aced,
title = "Genetics and personalized medicine--a role in statin therapy?",
abstract = "Pharmacogenetics uses the genetic variation in metabolic pathways to identify groups of patients who may respond differently in terms of therapeutic and adverse effects. Much clinical interest lies in drug metabolism and the opportunity to improve prescribing efficacy and safety. Owing to widespread use and increasing concern regarding side effects, statins are of significant interest in this area. Among other benefits, statins have been shown to improve lipid profiles and reduce coronary heart disease event rates in many populations. However, variability in drug response exists, and genetic variability may be a contributing factor. Our primary goal is to feature the most important genes involved in lipid metabolism, clinical outcomes, and statin-induced side effects, highlighting genome-wide association studies and the candidate gene approach.",
author = "Jaideep Patel and Thura Abd and Blumenthal, {Roger S.} and Khurram Nasir and Superko, {H. Robert}",
year = "2014",
month = "1",
language = "English (US)",
volume = "16",
pages = "384",
journal = "Current Atherosclerosis Reports",
issn = "1523-3804",
publisher = "Current Medicine Group",
number = "1",

}

TY - JOUR

T1 - Genetics and personalized medicine--a role in statin therapy?

AU - Patel, Jaideep

AU - Abd, Thura

AU - Blumenthal, Roger S.

AU - Nasir, Khurram

AU - Superko, H. Robert

PY - 2014/1

Y1 - 2014/1

N2 - Pharmacogenetics uses the genetic variation in metabolic pathways to identify groups of patients who may respond differently in terms of therapeutic and adverse effects. Much clinical interest lies in drug metabolism and the opportunity to improve prescribing efficacy and safety. Owing to widespread use and increasing concern regarding side effects, statins are of significant interest in this area. Among other benefits, statins have been shown to improve lipid profiles and reduce coronary heart disease event rates in many populations. However, variability in drug response exists, and genetic variability may be a contributing factor. Our primary goal is to feature the most important genes involved in lipid metabolism, clinical outcomes, and statin-induced side effects, highlighting genome-wide association studies and the candidate gene approach.

AB - Pharmacogenetics uses the genetic variation in metabolic pathways to identify groups of patients who may respond differently in terms of therapeutic and adverse effects. Much clinical interest lies in drug metabolism and the opportunity to improve prescribing efficacy and safety. Owing to widespread use and increasing concern regarding side effects, statins are of significant interest in this area. Among other benefits, statins have been shown to improve lipid profiles and reduce coronary heart disease event rates in many populations. However, variability in drug response exists, and genetic variability may be a contributing factor. Our primary goal is to feature the most important genes involved in lipid metabolism, clinical outcomes, and statin-induced side effects, highlighting genome-wide association studies and the candidate gene approach.

UR - http://www.scopus.com/inward/record.url?scp=84902768270&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902768270&partnerID=8YFLogxK

M3 - Article

VL - 16

SP - 384

JO - Current Atherosclerosis Reports

JF - Current Atherosclerosis Reports

SN - 1523-3804

IS - 1

ER -